Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Year-over-year gross profit growth rate
Percentile
P5
Near historical low
vs 3Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -33.24% |
| Q3 2025 | 44.58% |
| Q2 2025 | 46.56% |
| Q1 2025 | 6.67% |
| Q4 2024 | 17.89% |
| Q3 2024 | 46.90% |
| Q2 2024 | 4.61% |
| Q1 2024 | 39.20% |
| Q4 2023 | -20.01% |
| Q3 2023 | 16.47% |
| Q2 2023 | -40.73% |
| Q1 2023 | -4.20% |
| Q4 2022 | 160.18% |
| Q3 2022 | -60.07% |
| Q2 2022 | 12.44% |
| Q1 2022 | -16.27% |
| Q4 2021 | -16.92% |
| Q3 2021 | 25.79% |
| Q2 2021 | 15.74% |
| Q1 2021 | -6.44% |
| Q4 2020 | -2.08% |
| Q3 2020 | 6.42% |
| Q2 2020 | 1.16% |
| Q1 2020 | 16.95% |
| Q4 2019 | -7.44% |
| Q3 2019 | -1.98% |
| Q2 2019 | 13.42% |
| Q1 2019 | -8.57% |
| Q4 2018 | 6.56% |
| Q3 2018 | -1.46% |
| Q2 2018 | 9.07% |
| Q1 2018 | -10.20% |
| Q4 2017 | 4.03% |
| Q3 2017 | 3.72% |
| Q2 2017 | 15.47% |
| Q1 2017 | -8.89% |
| Q4 2016 | 11.59% |
| Q3 2016 | 0.25% |
| Q2 2016 | 14.30% |
| Q1 2016 | -4.83% |